CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Immunoprecise Antibodies Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Immunoprecise Antibodies Ltd
3204-4464 Markham St
Phone: (604) 806-0626p:604 806-0626 VICTORIA, BC  V8Z 7X8  Canada Ticker: IPAIPA
Business Summary
ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies. It has several subsidiaries in North America and Europe including entities, such as Talem Therapeutics LLC, BioStrand BV, ImmunoPrecise Antibodies (Canada) Ltd. and ImmunoPrecise Antibodies (Europe) B.V. (collectively, the IPA Family). Its Contract Research Organizations (CRO) services include B cell Select; Phage Display; DeepDisplay; Abthena Bispecifics; LucinaTech Humanization; Affinity Maturation; Immunization, hybridoma, sequencing; rPEx protein manufacturing, and Cell line development. The Company utilizes custom antigen modeling, target analysis using Natural Language Processing and the HYFTTM analysis to lay the groundwork for the subsequent experimental phases.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
7/31/20244/30/2024YesYes---

Industries
SIC Code Description
2834 Pharmaceutical preparations
2836 Biological products, except diagnostic substances
8734 Testing laboratories
7374 Computer processing and data preparation and processing services

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board MitchLevine 63 10/3/2023 10/3/2023
President, Chief Executive Officer, Director Jennifer L.Bath 5/1/2018 2/21/2018
Chief Financial Officer KristinTaylor 6/27/2024 9/19/2023
7 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Bioclue BV Fabrieksstraat, 7 Hamont-Achel Belgium
Biokey BV Fabrieksstraat, 7 Hamont-Achel Belgium
Biostrand BV Fabrieksstraat, 7 Hamont-Achel Belgium
3 additional Subsidiary records available in full report.

Business Names
Business Name
0496106 BC Ltd
BioClue B.V.
Bioclue BV
23 additional Business Names available in full report.

General Information
Number of Employees: 102 (As of 4/30/2023)
Outstanding Shares: 28,832,251 (As of 10/14/2024)
Stock Exchange: NASD
Fax Number: (250) 483-0309


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, November 22, 2024